Search results for "Drug Interactions"


 
Results 31 - 40 of about 66 for "Drug Interactions".
Sort by: Relevance | Newest | Oldest

Gout drug concerns; monthly buprenorphine injection OK'd

This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2018/02/gout-drug-concerns-monthly-buprenorphine-injection-okd.htm
1 Feb 2018

Drug interaction risks appear common among older patients being treated for epilepsy

Factors predicting higher drug interaction risk included having one or more comorbid condition versus zero comorbidities, having four or more comorbid conditions versus zero comorbidities, being eligible for the Medicare Part D Low-Income Subsidy, and not living in the northeastern U.S.
https://immattersacp.org/weekly/archives/2018/02/13/4.htm
13 Feb 2018

CDC expands recommendations for latent tuberculosis treatment

Expanded recommendations specifically include use in children, in persons co-infected with HIV/AIDS and latent tuberculosis, and by self-administration.
https://immattersacp.org/weekly/archives/2018/07/10/4.htm
10 Jul 2018

Expert panel recommends SGLT2 inhibitor or GLP-1 receptor agonist for patients with type 2 diabetes and CVD

The American College of Cardiology's new decision pathway also calls for repeated HbA1c screening and detailed clinician-patient risk discussions for patients with cardiovascular disease (CVD) who are diagnosed with type 2 diabetes.
https://immattersacp.org/weekly/archives/2018/12/04/2.htm
4 Dec 2018

MKSAP Quiz: 3-year history of dyspnea, cough

A 69-year-old man is evaluated for a three-year history of dyspnea and chronic productive cough. He was diagnosed with chronic obstructive pulmonary disease (COPD) two years ago and has been treated for three exacerbations in the past year. He is taking tiotropium, fluticasone/salmeterol, and albuterol inhalers. Which long-term treatment is most likely to reduce exacerbations?
https://immattersacp.org/weekly/archives/2019/03/05/3.htm
5 Mar 2019

New options no panacea for depression

Internists can have the greatest impact by continuing to be the first point of contact, treating mild to moderate depression, and explaining what may be available if first-line options fall short.
https://immattersacp.org/archives/2019/09/new-options-no-panacea-for-depression.htm
1 Sep 2019

Helping patients manage generic drug price increases

Generic drugs have recently become more expensive, from colchicine for gout to EpiPens for allergic reactions. Physicians are having trouble managing patients when their medicines suddenly rise in price.
https://immattersacp.org/archives/2019/09/helping-patients-manage-generic-drug-price-increases.htm
1 Sep 2019

Cluster headaches can hide in plain sight

Episodic cluster headaches and migraines are often confused, and more often than not, migraine is misdiagnosed as cluster.
https://immattersacp.org/archives/2019/11/cluster-headaches-can-hide-in-plain-sight.htm
1 Nov 2019

Shorter regimens can boost adherence in latent TB infection

Treatment is essential to reducing disease incidence.
https://immattersacp.org/archives/2020/01/shorter-regimens-can-boost-adherence-in-latent-tb-infection.htm
1 Jan 2020

Managing HIV with testing, prevention

Antiretroviral therapy has made an impact in treating HIV, but preexposure prophylaxis has created a huge opportunity in preventing infection, with internists poised to play a role.
https://immattersacp.org/archives/2020/03/managing-hiv-with-testing-prevention.htm
1 Mar 2020

Result Page: Prev   1   2   3   4   5   6   7   Next